Fiduciary Trust’s Disc Medicine IRON Stock Holding History

Fiduciary Trust’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$296K	Hold	4,051	–	–	﹤0.01%	752
2026 Q1	$259K	Hold	4,051	–	–	﹤0.01%	782
2025 Q4	$322K	Hold	4,051	–	–	﹤0.01%	694
2025 Q3	$268K	Hold	4,051	–	–	﹤0.01%	742
2025 Q2	$215K	Hold	4,051	–	–	﹤0.01%	786
2025 Q1	$201K	Hold	4,051	–	–	﹤0.01%	787
2024 Q4	$257K	Buy	+4,051	New	+$234K	﹤0.01%	611
2024 Q2	–	Sell	-4,051	Closed	-$252K	–	638
2024 Q1	$252K	Hold	4,051	–	–	﹤0.01%	588
2023 Q4	$234K	Buy	+4,051	New	+$207K	﹤0.01%	578
2022 Q4	–	Sell	-1,350	Closed	-$66K	–	633
2022 Q3	$66K	Hold	1,350	–	–	﹤0.01%	598
2022 Q2	$68K	Buy	+1,350	New	+$59.7K	﹤0.01%	616

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fiduciary Trust's IRON Position: Q2 2026 in Review

Fiduciary Trust held its Disc Medicine (IRON) position steady in Q2 2026 at 4,051 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #752.

Fiduciary Trust first reported a position in IRON in Q2 2022 and has held it in 11 quarters since. The position peaked at $322K in Q4 2025. 217 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

Fiduciary Trust held 4,051 shares of Disc Medicine worth $296K as of Q2 2026.
Fiduciary Trust left its Disc Medicine share count unchanged in Q2 2026.
Disc Medicine made up ﹤0.01% of Fiduciary Trust's portfolio in Q2 2026, its #752 holding.
Fiduciary Trust first reported a position in Disc Medicine in Q2 2022 and has held it in 11 quarters since.
Fiduciary Trust's Disc Medicine position peaked at $322K in Q4 2025.
217 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.